BR Broadridge Financial Solutions Inc

Pacer Advisors Inc. significantly reduced its stake in Broadridge Financial Solutions (NYSE: BR) by 37.1% during the third quarter, selling 5,606 shares and retaining 9,502 shares valued at $2.263 million. Despite this, other institutional investors increased their positions, and the company announced a quarterly dividend of $0.975 per share. Broadridge shares trade around $225.20, with a market cap of $26.29 billion and a P/E ratio of 28.83, while analysts maintain a consensus "Hold" rating with an average target price of $259.83.

Putnam Managed Municipal Income Trust (PMM) released its annual report for the fiscal year ended October 31, 2025, detailing its investment performance and financial position. The closed-end municipal bond fund reported a total return of +3.16% based on net asset value and +2.06% based on market price. The report also highlights the fund's managed distribution plan and significant investments in municipal bonds across various U.S. states and territories.

This article provides a technical analysis of Broadridge Financial Solutions Inc. (NYSE: BR), identifying a neutral sentiment across all time horizons and suggesting a wait-and-see approach. It highlights an exceptional 21.5:1 risk-reward setup targeting a 6.2% gain against a 0.3% risk. The analysis also details three distinct AI-generated trading strategies including position trading, momentum breakout, and risk hedging, tailored for various risk profiles.

CAE Inc. (NYSE:CAE) shares have recently risen above their 200-day moving average, trading at $31.1350 with a consensus price target of $34.33 from analysts. Despite beating quarterly EPS estimates ($0.17 vs. $0.14), the company missed revenue expectations ($898M vs. $1.13B), and while analyst sentiment is mixed, it leans positive with a "Moderate Buy" rating. Institutional investors show increased interest, with 67.36% of the company's stock owned by them.

Ellington Financial Inc. has increased its at-the-market (ATM) stock offering to $500 million, amending its equity distribution agreements and adding Citadel Securities and Moelis & Company as sales agents. This expansion allows the company to sell up to $500 million in common stock through six agents, with compensation up to 2.0% of gross proceeds. This announcement follows a recent Q3 2025 earnings report where Ellington Financial exceeded analyst forecasts for adjusted distributable earnings, despite missing revenue expectations.

Tonix Pharmaceuticals Holding Corp. announced it will raise approximately $20.0 million through a registered direct offering with Point72. The offering involves the sale of common stock and pre-funded warrants, with proceeds intended for commercialization of marketed products, pipeline development, and general corporate purposes. This financing aims to support the company's growth as a fully-integrated commercial stage biotechnology firm.